9th Sep 2020 06:57
Okyo Pharma Ltd - life sciences & biotechnology company - Raises GBP500,000 through the issue of convertible loan notes. The notes carry an interest rate of 2.15% compounding and have maximum term of four years. Proceeds will be used for further development of clinical pipeline.
Current stock price: 11.25 pence
Year-to-date change: more than doubled from 1.70p at December 31, 2019
By Tapan Panchal; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
OKYO.L